Cullinan Therapeutics IncNASDAQ:CGEM
- LAST PRICE12.5400
- TODAY'S CHANGE (%)0.3200 (2.6187%)
- Bid / Lots11.1900/ 1
- Ask / Lots14.6500/ 1
- Open / Previous Close12.2700 / 12.2200
- Day Range
- 52 Week Range
- Volume479,037
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | CGEM |
|---|---|---|
| 09:32 ET | 4945 | 12.14 |
| 09:33 ET | 4389 | 12.33 |
| 09:35 ET | 2500 | 12.205 |
| 09:37 ET | 732 | 12.3 |
| 09:39 ET | 890 | 12.34 |
| 09:42 ET | 15119 | 12.35 |
| 09:46 ET | 200 | 12.385 |
| 09:48 ET | 1300 | 12.34 |
| 09:50 ET | 1720 | 12.42 |
| 09:51 ET | 400 | 12.34 |
| 09:53 ET | 3000 | 12.44 |
| 09:55 ET | 2914 | 12.36 |
| 09:57 ET | 600 | 12.26 |
| 10:04 ET | 1523 | 12.195 |
| 10:06 ET | 600 | 12.24 |
| 10:08 ET | 927 | 12.32 |
| 10:09 ET | 1214 | 12.365 |
| 10:11 ET | 1661 | 12.3 |
| 10:13 ET | 100 | 12.29 |
| 10:15 ET | 100 | 12.29 |
| 10:18 ET | 100 | 12.285 |
| 10:20 ET | 300 | 12.29 |
| 10:22 ET | 100 | 12.29 |
| 10:24 ET | 316 | 12.345 |
| 10:26 ET | 1336 | 12.345 |
| 10:27 ET | 4542 | 12.3 |
| 10:29 ET | 2700 | 12.35 |
| 10:31 ET | 1100 | 12.325 |
| 10:33 ET | 2149 | 12.305 |
| 10:36 ET | 300 | 12.31 |
| 10:38 ET | 200 | 12.325 |
| 10:40 ET | 3608 | 12.34 |
| 10:42 ET | 100 | 12.37 |
| 10:44 ET | 9113 | 12.385 |
| 10:45 ET | 5532 | 12.29 |
| 10:51 ET | 1500 | 12.27 |
| 10:54 ET | 400 | 12.295 |
| 10:56 ET | 3593 | 12.24 |
| 10:58 ET | 4368 | 12.21 |
| 11:00 ET | 2968 | 12.19 |
| 11:02 ET | 4762 | 12.18 |
| 11:03 ET | 1154 | 12.17 |
| 11:05 ET | 2408 | 12.15 |
| 11:07 ET | 2187 | 12.25 |
| 11:09 ET | 800 | 12.34 |
| 11:12 ET | 200 | 12.325 |
| 11:14 ET | 1500 | 12.265 |
| 11:20 ET | 500 | 12.32 |
| 11:21 ET | 300 | 12.35 |
| 11:23 ET | 1800 | 12.36 |
| 11:25 ET | 1000 | 12.35 |
| 11:27 ET | 1362 | 12.35 |
| 11:30 ET | 17990 | 12.39 |
| 11:32 ET | 2635 | 12.54 |
| 11:34 ET | 2245 | 12.5 |
| 11:36 ET | 100 | 12.49 |
| 11:38 ET | 2000 | 12.59 |
| 11:39 ET | 300 | 12.62 |
| 11:41 ET | 200 | 12.62 |
| 11:43 ET | 300 | 12.68 |
| 11:45 ET | 1000 | 12.605 |
| 11:48 ET | 900 | 12.605 |
| 11:50 ET | 100 | 12.67 |
| 11:52 ET | 1500 | 12.68 |
| 11:54 ET | 200 | 12.66 |
| 11:56 ET | 12433 | 12.64 |
| 11:59 ET | 100 | 12.7 |
| 12:03 ET | 309 | 12.7 |
| 12:06 ET | 500 | 12.7 |
| 12:08 ET | 5361 | 12.6 |
| 12:10 ET | 2329 | 12.61 |
| 12:14 ET | 600 | 12.64 |
| 12:19 ET | 871 | 12.685 |
| 12:21 ET | 1311 | 12.68 |
| 12:24 ET | 100 | 12.69 |
| 12:26 ET | 386 | 12.69 |
| 12:30 ET | 1100 | 12.68 |
| 12:32 ET | 1100 | 12.66 |
| 12:33 ET | 200 | 12.64 |
| 12:35 ET | 250 | 12.63 |
| 12:42 ET | 719 | 12.64 |
| 12:44 ET | 300 | 12.68 |
| 12:46 ET | 300 | 12.67 |
| 12:48 ET | 4536 | 12.6 |
| 12:50 ET | 2900 | 12.5884 |
| 12:51 ET | 700 | 12.55 |
| 12:53 ET | 248 | 12.53 |
| 12:55 ET | 100 | 12.53 |
| 12:57 ET | 100 | 12.49 |
| 01:00 ET | 100 | 12.5 |
| 01:02 ET | 800 | 12.47 |
| 01:04 ET | 540 | 12.51 |
| 01:09 ET | 200 | 12.57 |
| 01:11 ET | 852 | 12.61 |
| 01:13 ET | 100 | 12.62 |
| 01:15 ET | 400 | 12.64 |
| 01:20 ET | 100 | 12.62 |
| 01:22 ET | 422 | 12.64 |
| 01:24 ET | 300 | 12.615 |
| 01:26 ET | 1906 | 12.605 |
| 01:29 ET | 768 | 12.605 |
| 01:33 ET | 1000 | 12.64 |
| 01:36 ET | 800 | 12.67 |
| 01:38 ET | 700 | 12.68 |
| 01:40 ET | 3447 | 12.61 |
| 01:44 ET | 700 | 12.58 |
| 01:45 ET | 587 | 12.5739 |
| 01:47 ET | 200 | 12.63 |
| 01:49 ET | 100 | 12.625 |
| 01:51 ET | 1029 | 12.625 |
| 01:54 ET | 881 | 12.59 |
| 01:58 ET | 821 | 12.6 |
| 02:03 ET | 3075 | 12.605 |
| 02:05 ET | 312 | 12.5711 |
| 02:07 ET | 1900 | 12.595 |
| 02:12 ET | 1100 | 12.7 |
| 02:14 ET | 100 | 12.69 |
| 02:18 ET | 100 | 12.69 |
| 02:21 ET | 200 | 12.65 |
| 02:23 ET | 300 | 12.69 |
| 02:27 ET | 400 | 12.7 |
| 02:32 ET | 100 | 12.74 |
| 02:34 ET | 1402 | 12.75 |
| 02:36 ET | 1000 | 12.72 |
| 02:38 ET | 600 | 12.76 |
| 02:41 ET | 612 | 12.78 |
| 02:43 ET | 700 | 12.78 |
| 02:48 ET | 200 | 12.74 |
| 02:50 ET | 590 | 12.73 |
| 02:54 ET | 7910 | 12.64 |
| 02:56 ET | 300 | 12.67 |
| 02:57 ET | 200 | 12.64 |
| 03:01 ET | 200 | 12.64 |
| 03:03 ET | 200 | 12.63 |
| 03:08 ET | 822 | 12.632 |
| 03:10 ET | 100 | 12.63 |
| 03:14 ET | 400 | 12.59 |
| 03:19 ET | 863 | 12.65 |
| 03:21 ET | 300 | 12.64 |
| 03:24 ET | 100 | 12.66 |
| 03:26 ET | 818 | 12.64 |
| 03:28 ET | 2251 | 12.6414 |
| 03:32 ET | 1200 | 12.6 |
| 03:33 ET | 2651 | 12.53 |
| 03:37 ET | 461 | 12.545 |
| 03:39 ET | 200 | 12.545 |
| 03:42 ET | 3480 | 12.55 |
| 03:44 ET | 1155 | 12.505 |
| 03:46 ET | 400 | 12.48 |
| 03:48 ET | 2661 | 12.45 |
| 03:50 ET | 900 | 12.475 |
| 03:51 ET | 600 | 12.475 |
| 03:53 ET | 14562 | 12.49 |
| 03:55 ET | 888 | 12.535 |
| 03:57 ET | 5553 | 12.555 |
| 04:00 ET | 86936 | 12.54 |
Nov 14, 2024
Cullinan Therapeutics Announces Preclinical Data for CLN-978, a CD19-directed T Cell Engager, to be Presented at ACR Convergence 2024, from 10:01AM ET on Thursday Nov 14, 2024 by Dow Jones
10:01AM ET on Thursday Nov 14, 2024 by Dow Jones
Nov 7, 2024
Press Release: Cullinan Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results, from 7:01AM ET on Thursday Nov 07, 2024 by Dow Jones
7:01AM ET on Thursday Nov 07, 2024 by Dow JonesCullinan Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results, from 7:01AM ET on Thursday Nov 07, 2024 by Dow Jones
7:01AM ET on Thursday Nov 07, 2024 by Dow Jones
Nov 5, 2024
Cullinan Therapeutics to Participate in Fireside Chat at Stifel 2024 Healthcare Conference, from 7:00AM ET on Tuesday Nov 05, 2024 by Dow Jones
7:00AM ET on Tuesday Nov 05, 2024 by Dow Jones
Nov 4, 2024
Cullinan Therapeutics to Present Preclinical Data for CLN-978, a CD19-directed T Cell Engager, at ACR Convergence 2024, from 7:00AM ET on Monday Nov 04, 2024 by Dow Jones
7:00AM ET on Monday Nov 04, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Cullinan Therapeutics Inc | 711.5M | -4.4x | --- |
Oruka Therapeutics Inc | 717.5M | -3.5x | --- |
CARGO Therapeutics Inc | 722.1M | -4.7x | --- |
Oculis Holding AG | 615.7M | -7.4x | --- |
Erasca Inc | 734.5M | -3.3x | --- |
Replimune Group Inc | 755.0M | -4.9x | --- |
Company Information
Cullinan Therapeutics, Inc., formerly Cullinan Oncology, Inc., is a biopharmaceutical company focused on developing modality-agnostic targeted therapies. It has a portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its pipeline includes CLN-619, CLN-978, Zipalertinib (CLN-081/TAS6417), CLN-049, CLN-418, and CLN-617. Its lead unpartnered program, CLN-619, is a humanized lgG1 monoclonal antibody (mAb) that binds to the stress induced ligands MICA and MICB (MICA/B), which are expressed on a variety of solid tumors and hematologic malignancies. CLN-978 is a novel, highly potent, half-life extended CD19xCD3 bispecific T cell engager construct. CLN-081/TAS6417 is a novel, orally available, covalent inhibitor of mutant epidermal growth factor receptor (EGFR). CLN-049 is a FLT3xCD3 T cell engaging bispecific antibody. CLN-418 is a B7H4 x 4-1BB bispecific immune activator.
Contact Information
- Headquarters
- One Main Street, Suite 1350CAMBRIDGE, MA, United States 02142
- Phone
- 617-410-4650
- Fax
- 302-655-5049
Executives
- Independent Chairman of the Board
- Anthony Rosenberg
- President, Chief Executive Officer, Director
- Nadim Ahmed
- Chief Financial Officer, Principal Financial Officer, Principal Accounting Officer
- Mary Fenton
- Chief Scientific Officer
- Jennifer Michaelson
- Chief Legal and Compliance Officer, Company Secretary
- Jacquelyn Sumer
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $730.2M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 58.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | -0.18 |
EPS | $-2.88 |
Book Value | $10.58 |
P/E Ratio | -4.4x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
